Emily Bongard

8PUBLICATIONS
34CO-AUTHORS
Software and application securityMedical molecular engineering of nucleic acids and proteinsSocial epidemiologyEpidemiological modellingMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 04, 2023
Penicillin allergy status and its effect on antibiotic prescribing, patient outcomes and antimicrobial resistance (ALABAMA): protocol for a multicentre, parallel-arm, open-label, randomised pragmatic trial.

Kelsey Fiona Armitage, Catherine E Porter, Shadia Ahmed

|Jan 24, 2023
Mixed-methods evaluation of a behavioural intervention package to identify and amend incorrect penicillin allergy records in UK general practice.

Marta Wanat, Marta Santillo, Ushma Galal

|Sep 21, 2022
Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC4E trial in 15 European countries.

Xiao Li, Joke Bilcke, Alike W van der Velden

|Jul 30, 2021
Primary care for patients with respiratory tract infection before and early on in the COVID-19 pandemic: an observational study in 16 European countries.

Alike W van der Velden, Eva A Bax, Emily Bongard

|Jul 22, 2021
Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries: A Descriptive Analysis Alongside the Randomised Controlled ALIC4E Trial.

Xiao Li, Joke Bilcke, Alike W van der Velden

|Jun 19, 2021
Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk.

Gail Hayward, Christopher C Butler, Ly-Mee Yu

Pageof 2

Frequent Collaborators

4 joint publications

Sarah Tonkin-Crine

4 joint publications

Christopher C Butler

3 joint publications

Marta Santillo

3 joint publications

Samuel Coenen